• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海鞘胺和麦瑞定在体外可稳定G-四链体并抑制端粒酶。

Ascididemin and meridine stabilise G-quadruplexes and inhibit telomerase in vitro.

作者信息

Guittat Lionel, De Cian Anne, Rosu Frédéric, Gabelica Valérie, De Pauw Edwin, Delfourne Evelyne, Mergny Jean-Louis

机构信息

Laboratoire de Biophysique, Muséum National d'Histoire Naturelle, INSERM UR 565, CNRS UMR 5153, 43 rue Cuvier, 75231 Paris cedex 05, France.

出版信息

Biochim Biophys Acta. 2005 Aug 5;1724(3):375-84. doi: 10.1016/j.bbagen.2005.04.023.

DOI:10.1016/j.bbagen.2005.04.023
PMID:15950388
Abstract

Ascididemin and Meridine are two marine compounds with pyridoacridine skeletons known to exhibit interesting antitumour activities. These molecules have been reported to behave like DNA intercalators. In this study, dialysis competition assay and mass spectrometry experiments were used to determine the affinity of ascididemin and meridine for DNA structures among duplexes, triplexes, quadruplexes and single-strands. Our data confirm that ascididemin and meridine interact with DNA but also recognize triplex and quadruplex structures. These molecules exhibit a significant preference for quadruplexes over duplexes or single-strands. Meridine is a stronger quadruplex ligand and therefore a stronger telomerase inhibitor than ascididemin (IC50=11 and >80 muM, respectively in a standard TRAP assay).

摘要

海鞘胺和麦瑞定是两种具有吡啶并吖啶骨架的海洋化合物,已知它们具有有趣的抗肿瘤活性。据报道,这些分子的行为类似于DNA嵌入剂。在本研究中,采用透析竞争试验和质谱实验来确定海鞘胺和麦瑞定对双链体、三链体、四链体和单链等DNA结构的亲和力。我们的数据证实,海鞘胺和麦瑞定与DNA相互作用,同时也能识别三链体和四链体结构。与双链体或单链相比,这些分子对四链体表现出显著的偏好。麦瑞定是一种更强的四链体配体,因此作为端粒酶抑制剂比海鞘胺更强(在标准TRAP试验中,IC50分别为11和>80 μM)。

相似文献

1
Ascididemin and meridine stabilise G-quadruplexes and inhibit telomerase in vitro.海鞘胺和麦瑞定在体外可稳定G-四链体并抑制端粒酶。
Biochim Biophys Acta. 2005 Aug 5;1724(3):375-84. doi: 10.1016/j.bbagen.2005.04.023.
2
Interactions of cryptolepine and neocryptolepine with unusual DNA structures.隐色木防己碱和新隐色木防己碱与异常DNA结构的相互作用。
Biochimie. 2003 May;85(5):535-47. doi: 10.1016/s0300-9084(03)00035-x.
3
Synthesis and evaluation of analogues of 10H-indolo[3,2-b]quinoline as G-quadruplex stabilising ligands and potential inhibitors of the enzyme telomerase.10H-吲哚并[3,2-b]喹啉类似物作为G-四链体稳定配体和端粒酶潜在抑制剂的合成与评价
Org Biomol Chem. 2004 Apr 7;2(7):981-8. doi: 10.1039/b316055f. Epub 2004 Mar 10.
4
Synthesis and in vitro antitumor activity of ring C and D-substituted phenanthrolin-7-one derivatives, analogues of the marine pyridoacridine alkaloids ascididemin and meridine.海洋吡啶并吖啶生物碱海鞘胺和海鞘甲胺类似物C环和D环取代菲咯啉-7-酮衍生物的合成及其体外抗肿瘤活性
Bioorg Med Chem. 2004 Aug 1;12(15):3987-94. doi: 10.1016/j.bmc.2004.06.006.
5
Synthesis and in vitro antitumor activity of phenanthrolin-7-one derivatives, analogues of the marine pyridoacridine alkaloids ascididemin and meridine: structure-activity relationship.菲咯啉 - 7 - 酮衍生物的合成及其体外抗肿瘤活性,海洋吡啶吖啶生物碱海鞘胺和麦立啶的类似物:构效关系
J Med Chem. 2003 Jul 31;46(16):3536-45. doi: 10.1021/jm0308702.
6
Selective recognition of G-qQuadruplex telomeric DNA by a bis(quinacridine) macrocycle.双(喹吖啶)大环化合物对G-四链体端粒DNA的选择性识别
J Am Chem Soc. 2003 Apr 23;125(16):4732-40. doi: 10.1021/ja021299j.
7
NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA.基于核磁共振的端粒酶抑制化合物与G-四链体DNA结合的模型。
Biochemistry. 1998 Sep 8;37(36):12367-74. doi: 10.1021/bi981330n.
8
Tri- and tetra-substituted naphthalene diimides as potent G-quadruplex ligands.作为高效G-四链体配体的三取代和四取代萘二亚胺
Bioorg Med Chem Lett. 2008 Mar 1;18(5):1668-73. doi: 10.1016/j.bmcl.2008.01.050. Epub 2008 Jan 18.
9
Synthesis and evaluation of quindoline derivatives as G-quadruplex inducing and stabilizing ligands and potential inhibitors of telomerase.喹吲哚啉衍生物作为G-四链体诱导和稳定配体以及端粒酶潜在抑制剂的合成与评价
J Med Chem. 2005 Nov 17;48(23):7315-21. doi: 10.1021/jm050041b.
10
Synthesis and in vitro antitumor activity of novel ring D analogues of the marine pyridoacridine ascididemin: structure-activity relationship.海洋吡啶吖啶类海鞘胺新的D环类似物的合成及其体外抗肿瘤活性:构效关系
J Med Chem. 2002 Aug 15;45(17):3765-71. doi: 10.1021/jm0208774.

引用本文的文献

1
Unlocking potent anti-tuberculosis natural products through structure-activity relationship analysis.通过构效关系分析揭示强效抗结核天然产物
Nat Prod Bioprospect. 2025 Jul 7;15(1):44. doi: 10.1007/s13659-025-00529-4.
2
Marine-Derived Anticancer Agents Targeting Apoptotic Pathways: Exploring the Depths for Novel Cancer Therapies.海洋来源的靶向细胞凋亡通路的抗癌药物:探索新型癌症治疗方法的深度。
Mar Drugs. 2024 Feb 28;22(3):114. doi: 10.3390/md22030114.
3
Combining Electrospray Mass Spectrometry (ESI-MS) and Computational Techniques in the Assessment of G-Quadruplex Ligands: A Hybrid Approach to Optimize Hit Discovery.
结合电喷雾质谱(ESI-MS)和计算技术评估 G-四链体配体:一种优化命中发现的混合方法。
J Med Chem. 2021 Sep 23;64(18):13174-13190. doi: 10.1021/acs.jmedchem.1c00962. Epub 2021 Sep 12.
4
Ascidian Toxins with Potential for Drug Development.具有药物开发潜力的贻贝毒素。
Mar Drugs. 2018 May 13;16(5):162. doi: 10.3390/md16050162.
5
Telomerase Inhibitors from Natural Products and Their Anticancer Potential.天然产物来源的端粒酶抑制剂及其抗癌潜力。
Int J Mol Sci. 2017 Dec 21;19(1):13. doi: 10.3390/ijms19010013.
6
Identification of a gene cluster for telomestatin biosynthesis and heterologous expression using a specific promoter in a clean host.利用清洁宿主中特定启动子鉴定端粒酶抑制剂生物合成基因簇并进行异源表达。
Sci Rep. 2017 Jun 13;7(1):3382. doi: 10.1038/s41598-017-03308-5.
7
Telomerase as a Cancer Target. Development of New Molecules.端粒酶作为癌症靶点:新型分子的研发
Curr Top Med Chem. 2016;16(22):2432-40. doi: 10.2174/1568026616666160212122425.
8
Pyridinoacridine alkaloids of marine origin: NMR and MS spectral data, synthesis, biosynthesis and biological activity.海洋来源的吡啶并吖啶生物碱:核磁共振和质谱光谱数据、合成、生物合成及生物活性
Beilstein J Org Chem. 2015 Sep 18;11:1667-99. doi: 10.3762/bjoc.11.183. eCollection 2015.
9
A mini review on pyridoacridines: Prospective lead compounds in medicinal chemistry.嘧啶并吖啶类化合物:药物化学中有前景的先导化合物的小型综述。
J Adv Res. 2015 Jan;6(1):63-71. doi: 10.1016/j.jare.2014.11.002. Epub 2014 Nov 15.
10
Marine pharmacology in 2005-2006: antitumour and cytotoxic compounds.2005 - 2006年海洋药理学:抗肿瘤及细胞毒性化合物
Eur J Cancer. 2008 Nov;44(16):2357-87. doi: 10.1016/j.ejca.2008.07.001. Epub 2008 Aug 11.